To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06119217
Title Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trishula Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | AUS

Facility Status City State Zip Country Details
Investigative Site Tucson Arizona 85704 United States Details
Investigative SIte Hot Springs Arkansas 71913 United States Details
Investigative Site Bakersfield California 93309 United States Details
Investigative Site Fullerton California 92835 United States Details
Investigative Site Los Angeles California 90095 United States Details
Investigative Site Denver Colorado 80218 United States Details
Investigative Site Saint Petersburg Florida 33705 United States Details
Investigative Site West Palm Beach Florida 33401 United States Details
Investigative Site Atlanta Georgia 30318 United States Details
Investigative Site Wichita Kansas 67214 United States Details
Investigative Site Baton Rouge Louisiana 70809 United States Details
Investigative Site Columbia Maryland 21044 United States Details
Investigative Site Burnsville Minnesota 55337 United States Details
Investigative Site Las Vegas Nevada 89119 United States Details
Investigative Site Florham Park New Jersey 07932 United States Details
Investigative Site Asheville North Carolina 28806 United States Details
Investigative Site Columbus Ohio 43219 United States Details
Investigative Site Eugene Oregon 97401 United States Details
Investigative Site Portland Oregon 97239 United States Details
Investigative Site Horsham Pennsylvania 19044 United States Details
Investigative Site Austin Texas 78705 United States Details
Investigative Site Dallas Texas 75246 United States Details
Investigative Site San Antonio Texas 78258 United States Details
Investigative Site Tyler Texas 75702 United States Details
Investigative Site Arlington Virginia 22205 United States Details
Investigative Site Norfolk Virginia 23502 United States Details
Investigative Site Roanoke Virginia 24014 United States Details
Investigative Site Milwaukee Wisconsin 53226 United States Details
Investigative Site Albury New South Wales 2640 Australia Details
Investigative Site Westmead New South Wales 2145 Australia Details
Investigative Site Herston Queensland 4029 Australia Details
Investigative Site Besançon 25030 France Details
Investigative Site Dijon 21079 France Details
Investigative Site Lille 59000 France Details
Investigative Site Paris 75013 France Details
Investigative Site Poitiers 86021 France Details
Investigative Site Genova 16132 Italy Details
Investigative Site Meldola 47014 Italy Details
Investigative Site Milano 20132 Italy Details
Investigative Site Pavia 27100 Italy Details
Investigative Site Puglia 70124 Italy Details
Investigative Site Verona 37134 Italy Details
Investigative Site Goyang-si 10408 Korea, Republic of Details
Investigative Site Seongam 13496 Korea, Republic of Details
Investigative Site Seongnam-si 13620 Korea, Republic of Details
Investigative Site Seoul 03080 Korea, Republic of Details
Investigative Site Seoul 03722 Korea, Republic of Details
Investigative Site Seoul 05505 Korea, Republic of Details
Investigative Site Seoul 06351 Korea, Republic of Details
Investigative Site Seoul 08308 Korea, Republic of Details
Investigative Site Barcelona 08009 Spain Details
Investigative Site Barcelona 08035 Spain Details
Investigative Site Madrid 28040 Spain Details
Investigative Site Madrid 28041 Spain Details
Investigative Site Madrid 28050 Spain Details
Investigative Site Majadahonda 28222 Spain Details
Investigative Site Pamplona 31008 Spain Details
Investigative Site Valencia 46009 Spain Details
Investigative Site Zaragoza 50009 Spain Details
Investigative Site Kaohsiung 833401 Taiwan Details
Investigative Site Taichung 40447 Taiwan Details
Investigative Site Tainan 70403 Taiwan Details
Investigative Site Taipei 112 Taiwan Details
Investigative Site Taoyuan Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field